Soroka Univ. Medical Center

Beersheba 8410101

1 studies enrolling now · 6 studies all time

What they study most

Bronchiectasis, Diabetes Mellitus, Type 2, Extrapulmonary Neuroendocrine Cancer (epNEC), Lung Diseases, Interstitial, Myocardial Infarction

Studies at this site

• DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy — Recruiting now
• Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine — Running, not enrolling
• A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis — Completed
• A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) — Completed
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM — Completed